A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 59,626 shares of IONS stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,626
Previous 59,626 -0.0%
Holding current value
$2.27 Million
Previous $2.84 Million 15.95%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$34.73 - $43.33 $1.42 Million - $1.77 Million
40,770 Added 216.22%
59,626 $2.45 Million
Q1 2023

May 11, 2023

SELL
$33.58 - $41.2 $29,550 - $36,256
-880 Reduced 4.46%
18,856 $674,000
Q4 2022

Feb 08, 2023

SELL
$37.12 - $46.52 $42,391 - $53,125
-1,142 Reduced 5.47%
19,736 $745,000
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $382,859 - $462,878
-11,415 Reduced 35.35%
20,878 $700,000
Q2 2021

Aug 10, 2021

SELL
$34.54 - $47.25 $766,788 - $1.05 Million
-22,200 Reduced 40.74%
32,293 $1.29 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $462,891 - $694,500
10,889 Added 24.97%
54,493 $2.45 Million
Q4 2020

Feb 11, 2021

SELL
$45.3 - $60.27 $2,491 - $3,314
-55 Reduced 0.13%
43,604 $2.47 Million
Q3 2020

Nov 12, 2020

SELL
$47.45 - $62.95 $2.42 Million - $3.21 Million
-50,941 Reduced 53.85%
43,659 $2.07 Million
Q2 2020

Aug 13, 2020

BUY
$46.85 - $61.05 $337,320 - $439,560
7,200 Added 8.24%
94,600 $5.58 Million
Q1 2020

Jun 05, 2020

BUY
$41.6 - $63.4 $3.64 Million - $5.54 Million
87,400 New
87,400 $4.13 Million
Q1 2020

May 13, 2020

SELL
$41.6 - $63.4 $3.99 Million - $6.09 Million
-96,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $75,390 - $91,378
1,400 Added 1.48%
96,000 $5.8 Million
Q3 2019

Nov 08, 2019

BUY
$59.06 - $72.15 $5.11 Million - $6.24 Million
86,500 Added 1067.9%
94,600 $5.67 Million
Q2 2019

Aug 09, 2019

BUY
$62.09 - $86.14 $502,929 - $697,734
8,100 New
8,100 $521,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.41B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.